5321 | CITI program | | 04/01/2023 12:08:17 | |
5322 | Citi Program course | | 28/12/2022 22:38:20 | |
5323 | GCP | | 29/12/2022 16:39:28 | |
5324 | CITI conflict of interest | | 29/12/2022 17:44:51 | |
5325 | CITI basic course | | 29/12/2022 17:45:32 | |
5326 | GCP1 ICH focus | | 29/12/2022 17:45:48 | |
5327 | GCP2 international focus | | 29/12/2022 17:46:02 | |
5328 | GCP3 good clinical practice | | 29/12/2022 17:46:31 | |
5329 | responsible conduct of research | | 29/12/2022 17:46:50 | |
5330 | GCP | | 29/12/2022 22:15:48 | |
5331 | Citi Program | | 30/12/2022 23:29:07 | |
5332 | CITI program | | 31/12/2022 00:31:20 | |
5333 | GCP 2022 | | 31/12/2022 12:14:21 | |
5334 | Good Clinical Practice & Human Subject Protection Training Program 2022 | | 01/01/2023 12:17:15 | |
5335 | GCP (U.S. FDA Focus) for IRB members, Researchers, Faculty members | | 02/01/2023 22:41:24 | |
5336 | GCP Clinical Trials Involving Investigational Devices for IRB members, Researchers, Faculty members | | 02/01/2023 22:42:08 | |
5337 | Good clinical practice and human subject protection training for certificate | | 02/01/2023 22:53:23 | |
5338 | GCP training | | 03/01/2023 08:45:24 | |
5339 | Importance of GCP | | 03/01/2023 09:52:25 | |
5340 | Standard Course in Clinical Trials and GCP training Program 2021 | | 03/01/2023 14:15:55 | |